Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_641954852c16dacf58175fac03e4453e http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_00cc4956297dccc03c9fac7a78f75360 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2077 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1635 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0007 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0056 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5513 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4525 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4525 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-551 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 |
filingDate |
2006-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6df1160e5c21e61d30450d3b266993cc |
publicationDate |
2007-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2007050697-A2 |
titleOfInvention |
Compositions and methods for the administration psychotropic drugs which modulate body weight |
abstract |
Embodiments of the invention describe compositions and methods for the administration of fast disintegrating atypical antipsychotics, metabolites of atypical antipsychotics, and antidepressants which reduce weight in patients previously taking conventional formulation of atypical antipsychotics and antidepressants. In a preferred embodiment said fast dissolving atypical antipsychotic is FAZACLO. In another preferred embodiment said fast dissolving metabolite of an atypical antipsychotic is desmethyl clozapine. In another preferred embodiment said fast dissolving antidepressant is paroxetine. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11738035-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10519175-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11564935-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013100870-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11447510-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11149044-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10603272-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11180517-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11505564-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11629159-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013081567-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009150665-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10954259-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10947257-B2 |
priorityDate |
2005-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |